De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: A subtype of MDS with distinct hematological and prognostic features?
- 30 November 1993
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 17 (11) , 921-926
- https://doi.org/10.1016/0145-2126(93)90038-m
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical significance of the del(20q) chromosome in hematologic disordersCancer Genetics and Cytogenetics, 1992
- CytogeneticsHematology/Oncology Clinics of North America, 1992
- Correlations between cytogenetics and morphology in myelodysplastic syndromesAnnals of Hematology, 1990
- Prognostic significance of single chromosome abnormalities in preleukemic statesCancer Genetics and Cytogenetics, 1989
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- Chromosome studies in preleukemic states: V. Prognostic significance of single versusmultiple abnormalitiesCancer, 1986
- Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromesBlood, 1986
- Hematologic manifestations associated with deletions of the long arm of chromosome 20Cancer Genetics and Cytogenetics, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Sideroblastic Anaemia, Mitochondria and Erythroblastic IronBritish Journal of Haematology, 1965